Voyager Therapeutics, Inc. SEC filings VYGR
Voyager Therapeutics, Inc. has 681 filings in SEC EDGAR's recent list, going back to Apr 23, 2015. Its latest annual report, Form ARS, was filed on Apr 28, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 21, 2026 (officer or director change). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 424B3 | Prospectus | Dec 1, 2025 | — |
| S-3 | Shelf registration | Nov 10, 2025 | — |
| S-8 | Employee stock plan registration | Jun 9, 2025 | — |
| S-8 | Employee stock plan registration | Mar 11, 2025 | — |
| S-8 | Employee stock plan registration | Aug 6, 2024 | — |
| S-8 | Employee stock plan registration | Feb 28, 2024 | — |
| 424B5 | Prospectus supplement | Jan 8, 2024 | — |
| 424B5 | Prospectus supplement | Jan 4, 2024 | — |
| S-8 | Employee stock plan registration | Mar 7, 2023 | — |
| 424B3 | Prospectus | Nov 15, 2022 | — |
| S-3 | Shelf registration | Nov 8, 2022 | — |
| S-8 | Employee stock plan registration | Mar 8, 2022 | — |
| S-8 | Employee stock plan registration | Feb 26, 2021 | — |
| S-8 | Employee stock plan registration | Mar 3, 2020 | — |
| 424B3 | Prospectus | Dec 3, 2019 | — |
| S-3 | Shelf registration | Nov 6, 2019 | — |
| S-8 | Employee stock plan registration | Feb 26, 2019 | — |
| S-8 | Employee stock plan registration | Mar 14, 2018 | — |
| 424B5 | Prospectus supplement | Nov 8, 2017 | — |
| 424B5 | Prospectus supplement | Nov 6, 2017 | — |
| S-8 | Employee stock plan registration | Mar 15, 2017 | — |
| S-3/A | Filing | Dec 19, 2016 | — |
| S-3 | Shelf registration | Dec 1, 2016 | — |
| S-8 | Employee stock plan registration | Mar 17, 2016 | — |
| S-8 | Employee stock plan registration | Nov 12, 2015 | — |
| 424B4 | Prospectus | Nov 12, 2015 | — |
| S-1/A | Amended registration statement | Nov 6, 2015 | — |
| S-1/A | Amended registration statement | Nov 4, 2015 | — |
| S-1/A | Amended registration statement | Oct 30, 2015 | — |
| S-1/A | Amended registration statement | Oct 28, 2015 | — |
| S-1 | Registration statement | Oct 9, 2015 | — |
Showing 31 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- VYGR (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Lexington, MA
- SEC filer status
- Accelerated filer, Smaller reporting company
- SEC CIK
- 1640266
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.